Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Marja-Riitta Taskinen
With
Göteborg University
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
persons who have provided written consent
apo-CIII loss-of-function mutation (heterozygous) or apo-CIII gain-of-function mutations (heterozygous) or TM6SF2 E167K mutation (homozygous) or PNLPLA3 I148M or apoE or LIPG or ANGPTL3 or ANGPTL8 LOF and GOF variants. Control group without any of known risk variants in these genes.
Hemoglobin A1c \< 6.5%
Body mass index between 18.5 and 40 kg/m²
Estimated glomerular filtration rate \> 60 ml/min/1.73 m² at inclusion
You may not be if
Patients with Type 1 and 2 diabetes, BMI \> 40 kg/m2,
ApoE2/2 phenotype, thyrotropin concentration outside normal range,